Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: Results from a randomized trial

JAMA

Volumn 286, Issue 19, 2001, Pages 2405-2412

  Morrow, David A ^a   Cannon, Christopher P ^a   Rifai, Nader ^g   Frey, Martin J ^d   Vicari, Ralph ^e   Lakkis, Nasser ^f   Robertson, Debbie H ^c   Hille, Darcy A ^c   DeLucca, Paul T ^c   DiBattiste, Peter M ^c   Demopoulos, Laura A ^c   Weintraub, William S ^b   Braunwald, Eugene ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b EMORY UNIVERSITY   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

^d Heart Center of Sarasota   (United States)

^e Holmes Regional Medical Center   (United States)

^f BAYLOR COLLEGE OF MEDICINE   (United States)

^g BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPARIN; TIROFIBAN; TROPONIN I; TROPONIN T;

ARTICLE; CARDIOVASCULAR DISEASE; CHEMOLUMINESCENCE; CLINICAL PATHWAY; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DIAGNOSTIC TEST; ENZYME IMMUNOASSAY; EXERCISE TEST; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; PRIORITY JOURNAL; PROGNOSIS; PROVOCATION TEST; UNSTABLE ANGINA PECTORIS;

EID: 0035930101     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.286.19.2405     Document Type: Article

References (21)

1. ACC/ AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
2. A classification of unstable angina revisited
3. The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: A meta-analysis
4. Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection
5. Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels
6. Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban
7. Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: A TIMI 11B substudy
8. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban (TACTICS-TIMI 18)
9. Invasive versus conservative strategies in unstable angina and non-Q-wave myocardial infarction following treatment with tirofiban: Rationale and study design of the international TACTICS-TIMI 18 Trial
10. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction
11. Clinical Efficacy of three assays for cardiac troponin I for risk stratification in acute coronary syndromes: A Thrombolysis in Myocardial Infarction (TIMI) 11B substudy
12. It's time for a change to a troponin standard
13. Elevated cardiac troponin I predicts a high-risk angiographic anatomy of the culprit lesion in unstable angina
14. Angiographic findings in patients with refractory unstable angina according to troponin T status
15. Elevations in troponin T are associated with abnormal tissue level perfusion: A TACTICS-TIMI 18 Substudy
16. Benefit of glycoprotein IIb/IlIa inhibition in patients with acute coronary syndromes and troponin t-positive status: The paragon-B troponin T substudy
17. Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: The FRISC II invasive randomised trial
18. Troponins in patients with acute coronary syndromes: Biologic, diagnostic, and therapeutic implications
19. Myocardial infarction redefined a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction
20. Elevation of troponin I levels in patients without evidence of myocardial injury
21. Optimizing the treatment of unstable angina